Tag

Vaccine Development

Texas A&M Health Science Center solidifies growth trajectory with unprecedented research expenditures milestone

January 15, 2015

With an unprecedented 34 percent increase in 2014, Texas A&M Health Science Center has crossed the $100 million threshold in total annual research expenditures, which includes a nearly 68 percent increase in funding from federal sources.

Protecting Our Nation: Pandemic Influenza Vaccine Facility

November 4, 2014

Texas Governor Rick Perry, Texas A&M University System Chancellor John Sharp, Texas A&M Health Science Center CEO Brett Giroir, M.D., and officials from the U.S. Department of Health and Human Services (HHS), State of Texas and biopharmaceutical company GSK dedicated a national pandemic influenza vaccine manufacturing facility in Bryan, Texas, which when complete will serve as an anchor for the Texas A&M Biocorridor – a rapidly evolving hub of economic development and scientific discovery that is swiftly positioning Texas as the third coast in biotechnology.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility, on track for 2016 start-up phase

September 18, 2014

Texas Governor Rick Perry, Texas A&M University System Chancellor John Sharp, Texas A&M Health Science Center CEO Brett Giroir, M.D., and officials from the U.S. Department of Health and Human Services (HHS), State of Texas and biopharmaceutical company GSK today dedicated a national pandemic influenza vaccine manufacturing facility in Bryan, Texas, which when complete will serve as an anchor for the Texas A&M Biocorridor.

Q&A: Pandemic flu – Preparing for the next unknown

September 15, 2014

While much attention has been focused on the Ebola outbreak that has claimed over 2,000 lives across West Africa, there are other, more easily spread infectious diseases lurking – like pandemic influenza virus. Gerald Parker, D.V.M., Ph.D., vice president for public health preparedness and response at the Texas A&M Health Science Center, speaks about pandemic influenza, its implications for society, and actions the public health community can take to mitigate damage and save lives.

Texas A&M forges path for rapid, flexible vaccine delivery

July 17, 2014

Vaccines are among the greatest achievements in the history of public health. However, past challenges with vaccine development processes and frequent shortages during times of need have highlighted the importance of more extensive and reliable manufacturing operations.